In 2003, an international working group last reported on recommendations for diagnosis, response assessment, and treatment outcomes in acute myeloid leukemia (AML). Since that time, considerable progress has been made in elucidating the molecular pathogenesis of the disease that has resulted in the identification of new diagnostic and prognostic markers. Furthermore, therapies are now being developed that target disease-associated molecular defects. Recent developments prompted an international expert panel to provide updated evidence- and expert opinion-based recommendations for the diagnosis and management of AML, that contain both minimal requirements for general practice as well as standards for clinical trials. A new standardized reporting system for correlation of cytogenetic and molecular genetic data with clinical data is proposed.

Döhner, H., Estey, E., Amadori, S., Appelbaum, F., Büchner, T., Burnett, A., et al. (2010). Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. BLOOD, 115(3), 453-474 [10.1182/blood-2009-07-235358].

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

AMADORI, SERGIO;LO COCO, FRANCESCO;
2010-01-21

Abstract

In 2003, an international working group last reported on recommendations for diagnosis, response assessment, and treatment outcomes in acute myeloid leukemia (AML). Since that time, considerable progress has been made in elucidating the molecular pathogenesis of the disease that has resulted in the identification of new diagnostic and prognostic markers. Furthermore, therapies are now being developed that target disease-associated molecular defects. Recent developments prompted an international expert panel to provide updated evidence- and expert opinion-based recommendations for the diagnosis and management of AML, that contain both minimal requirements for general practice as well as standards for clinical trials. A new standardized reporting system for correlation of cytogenetic and molecular genetic data with clinical data is proposed.
21-gen-2010
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/15 - MALATTIE DEL SANGUE
English
Con Impact Factor ISI
Prognosis; Age Factors; Adolescent; Young Adult; Middle Aged; Risk Factors; Leukemia, Myeloid, Acute; Adult; Health Planning Guidelines; International Cooperation; Humans
Döhner, H., Estey, E., Amadori, S., Appelbaum, F., Büchner, T., Burnett, A., et al. (2010). Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. BLOOD, 115(3), 453-474 [10.1182/blood-2009-07-235358].
Döhner, H; Estey, E; Amadori, S; Appelbaum, F; Büchner, T; Burnett, A; Dombret, H; Fenaux, P; Grimwade, D; Larson, R; LO COCO, F; Naoe, T; Niederwieser, D; Ossenkoppele, G; Sanz, M; Sierra, J; Tallman, M; Löwenberg, B; Bloomfield, C
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/12313
Citazioni
  • ???jsp.display-item.citation.pmc??? 1217
  • Scopus 2746
  • ???jsp.display-item.citation.isi??? 2582
social impact